Previous 10 | Next 10 |
Arrowhead Pharmaceuticals (NASDAQ: ARWR ) : Q3 GAAP EPS of -$0.13 beats by $0.04 . More news on: Arrowhead Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
- Conference Call and Webcast Today, August 5 at 4:30 p.m. EDT Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial results for its fiscal third quarter ended June 30, 2020. The company is hosting a conference call at 4:30 p.m. EDT to discuss results. Conference C...
The following slide deck was published by Arrowhead Pharmaceuticals, Inc. in conjunction with this Read more ...
Arrowhead Pharmaceuticals (NASDAQ: ARWR ) has earned a $20M milestone payment from Amgen (NASDAQ: AMGN ) triggered by the start of dosing in a Phase 2 clinical trial evaluating AMG 890 in patients with elevated levels of lipoprotein (a) [Lp(a)] which, according to emerging research, ...
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has earned a $20 million milestone payment from Amgen following the administration of the first dose of AMG 890, formerly referred to as ARO-LPA, in a Phase 2 clinical study. The study is evaluating the efficacy, safety, an...
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) is hosting a key opinion leader webinar today at 12:00 PM EDT on ARO-ENaC, the company’s investigational RNA interference (RNAi) therapeutic being developed as a treatment for patients with cystic fibrosis (CF). The webinar features a p...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Premarket - Albertsons (NYSE: ACI ) will issue its first earnings report since the IPO. The stock attracted a wave of bullish ratings last month and is likely to have seen a positive effect on sales from the pandemic. The last grocery store operator to go public before Albertsons w...
**This article was originally published for ROTY subscribers on May 16, but has been updated where necessary. Despite recent share price appreciation, the story remains in early innings with substantial upside potential ahead as 2H 2020 catalysts approach (updated HBV data, AAT 6 month biop...
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that on July 28, 2020, at 12:00 p.m. EDT it will host a key opinion leader webinar on ARO-ENaC, the company’s investigational RNA interference (RNAi) therapeutic being developed as a treatment for patients with c...
News, Short Squeeze, Breakout and More Instantly...
Arrowhead Pharmaceuticals Inc. Company Name:
ARWR Stock Symbol:
NASDAQ Market:
2024-05-13 10:30:04 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for ARWR on May 13, 2024 08:34AM ET. The previous analyst recommendation was Equal-Weight. ARWR was trading at $22.39 at issue of the analyst recommendation. The overall analyst consensus : ...
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly fina...